|
|
 |
|
Viewing report
|
|
|
|
Top 10 Companies in the German Life Sciences Industry: IT Spending Predictor 2010
Datamonitor, Sep 2010, Pages: 92
This databook provides estimates of IT spending for the top 10 companies in the German Life sciences industry. The databook is a comprehensive source of IT spending by company, including assessment by technology and channel. The databook also provides information on the IT contracts of these companies where available.
- The view of the top 10 companies in the German Life sciences sector in terms of IT spending
- A breakdown of the estimated IT budget by technology for each of the top 10 companies
- A breakdown of the estimated IT budget by channel for each of the top 10 companies
- Details of IT services contracts by company where available
The top 10 companies in the German life sciences industry in terms of estimated IT spending spent the largest portion of their IT budgets on services, a segment that accounted for about 28% of the IT budgets among these firms. This was followed by spending on hardware and software.
Among the top 10 companies, a major portion of IT spending is allocated to internal IT. Internal IT alone accounted for approximately 30% of the total estimated IT spending by these companies. Bayer AG remained the leading company in terms of IT spending, followed by Heraeus Holding GmbH and Boehringer Ingelheim GmbH.
- Gain insight into IT budget breakdown of top10 companies in German life sciences industry and identify notable areas of allocation
- Identify organizations with top IT expenditures in your target markets
- Leverage IT spending pattern information to tailor account targeting based on company demographics
Customers who bought this item also bought
Biotechnology in Germany
Biotechnology in Europe
Top 10 Companies in the Italian Life Sciences Industry: IT Spending Predictor 2010
Biotech Investment and Business Trends: Weathering the Economic Storm
Strategies for Building Biologics Capabilities and Franchises
Option and Evaluation Agreements in Pharma and Biotech, 2nd Edition
Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics, 4th Edition
Biologics Pipelines: Who Has the Next Promising Recombinant Proteins?
Pre-Clinical Stage Partnering Terms and Agreements in Pharma, Biotech and Diagnostics, 2nd Edition
Epigenetics: Tools, Diagnostics, Drugs and World Market
|
|
|
|
